PapersPMID:42646594
Sertraline as an Antidepressant and Inflammatory Cytokines in Depressive Disorders: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
- Population, every finding
- adults treated with sertraline for depressive disorders, pooled across trials with mixed comorbidities including coronary heart disease and chronic kidney disease
No finding here moved its endpoint.
What did not
How to read these marks →“Overall, the pooled results suggest that sertraline did not significantly alter circulating levels of IL-6, IL-10, or TNF-α across the included studies.”
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with depressive disorders (including comorbid coronary heart disease, chronic kidney disease, and PTSD) enrolled in 10 pooled randomized placebo-controlled trials of sertraline assessing inflammatory cytokines
- Participants
- not reported
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 3
sertraline